Home

Paul Peter Tak, CEO: Candel Therapeutics CADL Sell · Filed 25/03/20

Trade details

Type
Insider sale
Amount
$226,020.44
Shares · price
25,772 sh · $8.77 a share
Held after
226,140 sh
Trade date
25/03/18
Filed
25/03/20
Days to filing
2 days

Sold 10.2% of holdings

Share of holding sold
10.2%

Candel Therapeutics trades, last 26 weeks

What else happened in Candel Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Paul Peter Tak's recent trades

  • Paul Peter Tak

    Planned sale10b5-1 planCandel Therapeutics

    $3.4M

    Filed 09/10

  • Paul Peter Tak

    Sell10b5-1 planCandel Therapeutics

    $3,600

    Filed 25/03/20

  • Paul Peter Tak

    Planned sale10b5-1 planCandel Therapeutics

    $654.4K

    Filed 25/03/18

  • Paul Peter Tak

    SellCandel Therapeutics

    $156.9K

    Filed 25/01/17

  • Paul Peter Tak

    Planned saleCandel Therapeutics

    $156.6K

    Filed 25/01/15